Mitral Regurgitation Following Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention-Prevalence,

Harish Sharma1, Ashwin Radhakrishnan1, Peter Nightingale2

  • 1Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, University Hospitals Birmingham, Birmingham, United Kingdom.

Insights

Mitral regurgitation (MR) after acute myocardial infarction (AMI) affects over a quarter of patients and is linked to worse survival, even in mild cases. Risk factors include older age and reduced left ventricular ejection fraction.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Echocardiography

Background:

  • Mitral regurgitation (MR) following acute myocardial infarction (AMI) is a known complication with significant prognostic implications.
  • Existing data on the prevalence and impact of MR post-AMI are varied, necessitating further investigation into risk factors and outcomes.

Purpose of the Study:

  • To determine the prevalence of mitral regurgitation in patients following acute myocardial infarction.
  • To identify risk factors associated with the development of MR post-AMI.
  • To evaluate the impact of MR on patient outcomes and mortality.

Main Methods:

  • A cohort of 1000 consecutive patients admitted with AMI between 2016-2017 were analyzed.
  • Transthoracic echocardiography was performed pre-discharge to assess for MR.
  • Patient demographics, clinical history, AMI characteristics, treatment details, and long-term mortality data were collected and analyzed.

Main Results:

  • Mitral regurgitation was present in 29% of patients (294/1000), predominantly mild (76%).
  • Patients with MR were older, had worse left ventricular ejection fraction (LVEF), and reduced creatinine clearance.
  • Higher rates of hypertension, heart failure, previous MI, and severe coronary artery disease were observed in patients with MR. Delayed revascularization (>72 hours) was associated with increased MR likelihood in NSTEMI patients. Even mild MR was linked to increased mortality over a mean follow-up of 3.2 years.

Conclusions:

  • Mitral regurgitation is a common complication after AMI, affecting over a quarter of patients.
  • The presence of MR, even when mild, is independently associated with increased mortality post-AMI.
  • Risk factors include older age, reduced LVEF, and delayed revascularization in NSTEMI, highlighting the need for early detection and management.

Related Concept Videos

Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
88
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
95
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
61
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
128
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
78
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
78